Baidu
map
CHEMISTRYSELECT 润色咨询

ChemistrySelect

出版年份:暂无数据 年文章数:9922 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:14.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-06-08 ms8933482113232354

    审稿速度:3.0
    经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2021-12-29 衣谷

    方法需要详细/具体到什么程度?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    一般方法中要求写什么东西?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2021-06-11 秋虫

    审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly.
    审稿人意见:Reviewer's Responses to Questions

    1. Please rate the importance of the reported results

    Reviewer #1: Very important

    --------------------

    2. Please rate the citation of previous publications

    Reviewer #1: Appropriate

    --------------------

    3. Please comment on the quality of the Supporting Information

    Reviewer #1: No improvement required

    --------------------

    4. Please rate the verification of hypotheses and conclusions by the presented data

    Reviewer #1: Minor inconsistencies

    --------------------

    5. Please rate the length of the manuscript

    Reviewer #1: Concise

    --------------------

    6. Please comment on the quality of the language/manuscript preparation and presentation

    Reviewer #1: Minor issues with the language/presentation
    1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.
    2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.
    修回一天后:reject
    有病吗

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2021-04-08 ms4000001115609417

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:电化学;锂硫电池;催化材料
    经验分享:2021.2.4 投稿
    2021.2.6 送审
    2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信
    2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了
    2021.4.1 提交修改稿
    目前等待中

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-05-06 ms8415407993286297

    2020.01.10投稿,两三天后送审
    大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。
    2020.05.05 收到邮件说文章在制作中。
    有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。
    急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-05-22 ms3136433039918945

    审稿速度:2.0
    经验分享:2020.02.16 投稿
    2020.02.19 送审
    2020.04.15 大修,两个审稿人的意见
    2020.04.24 修回
    2020.04.30 编辑让修改格式。
    2020.05.07 最终接受!
    要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。
    但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-05-10 ms6502024518793471

    补了数据录用
    收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作
    希望35楼同学可以早日看见

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-03-31 ms4560175821706816

    1月10号投稿
    2月15号回复审稿意见
    3月6号接收
    3月26号出版
    速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=861580, encodeId=19378615802e, content=审稿速度:3.0<br>经验分享:我的文章已经接收了几个月了 在网上都能查到我的文章了 但是投稿系统里一直显示submissions in production 是什么意思呢 需要我们做什么才能submissions with production completed , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52e85413993, createdName=ms8933482113232354, createdTime=Mon Jun 08 10:56:20 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106929, encodeId=ea31110692997, content=方法需要详细/具体到什么程度?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106930, encodeId=6dfd1106930ca, content=一般方法中要求写什么东西?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972741, encodeId=c0e19e27412a, content= 审稿意见:Our impression is that the above-mentioned manuscript might indeed become suitable for publication in ChemistrySelect. However, the criticism from the referees requires that we defer our final decision until you have considered the remarks (see below) and revised your manuscript accordingly. <br>审稿人意见:Reviewer's Responses to Questions<br><br>1. Please rate the importance of the reported results<br><br>Reviewer #1: Very important<br><br>--------------------<br><br>2. Please rate the citation of previous publications<br><br>Reviewer #1: Appropriate<br><br>--------------------<br><br>3. Please comment on the quality of the Supporting Information<br><br>Reviewer #1: No improvement required<br><br>--------------------<br><br>4. Please rate the verification of hypotheses and conclusions by the presented data<br><br>Reviewer #1: Minor inconsistencies<br><br>--------------------<br><br>5. Please rate the length of the manuscript<br><br>Reviewer #1: Concise<br><br>--------------------<br><br>6. Please comment on the quality of the language/manuscript preparation and presentation<br><br>Reviewer #1: Minor issues with the language/presentation<br>1. Because there are so many studies on the detection of 1O2, a highly reactive molecule, that plays a role in various cancerous processes, the unique and outstanding characteristics of the present work must be highlighted.<br>2. Moreover, the novelty and advantages of the proposed work have to be clearly stated.<br>修回一天后:reject<br>有病吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/0A841B4BFBA041C21AE08F643525398F/100, createdBy=918c2246107, createdName=秋虫, createdTime=Fri Jun 11 07:38:38 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955199, encodeId=c070955199b0, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:电化学;锂硫电池;催化材料<br>经验分享:2021.2.4 投稿<br>2021.2.6 送审<br>2021.3.21 等了将近七周,由于没有其他联系方式,给总部写了封语气委婉的催稿信<br>2021.3.24 收到审稿意见,说我的第一个意见早就上传了,第二个审稿人的意见本应该被上传,但是被delayed,推测是编辑太忙忘了<br>2021.4.1 提交修改稿<br>目前等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c445478206, createdName=ms4000001115609417, createdTime=Thu Apr 08 14:23:39 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860241, encodeId=972486024146, content=2020.01.10投稿,两三天后送审<br> 大约两个月后返修,进行了三次返修,两次修内容,一次修格式,整个期间大概一个半月。<br> 2020.05.05 收到邮件说文章在制作中。<br> 有个问题,每次编辑给邮件都会有开源的连接,而投稿时并没有选择开源。2020.05.05 收到邮件说让注册威廉作者服务账号,很是疑惑。问过其他投威廉旗下非chemistryselect的同学,他们并没有遇到这样的情况,想问问其他人是否也遇到过这种情况,是每个投稿接收必须的程序还是只有开源才有。<br> 急切想知道答案,有经验的同学希望能得到你的指点。有问题的大家可以互相交流。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Wed May 06 10:53:58 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860869, encodeId=254886086949, content=审稿速度:2.0<br>经验分享:2020.02.16 投稿<br> 2020.02.19 送审<br> 2020.04.15 大修,两个审稿人的意见<br> 2020.04.24 修回<br> 2020.04.30 编辑让修改格式。<br> 2020.05.07 最终接受!<br> 要拿这篇文章毕业,又赶上疫情不能返校,所以很忐忑,好在审稿人给的评价高,让补的数据也是紧密围绕论文体系的,所以恰好都有,不需要返校补充数据。<br> 但是接收了半个月了还没online,遇到和35楼和36楼一样的问题。希望两个楼的同学早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375a5413962, createdName=ms3136433039918945, createdTime=Fri May 22 19:52:34 CST 2020, time=2020-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860392, encodeId=7ee8860392e0, content=补了数据录用<br> 收到邮件说一些问题需要修改 给了一个wiley的网址 但是不知道怎么操作 <br> 希望35楼同学可以早日看见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d05414083, createdName=ms6502024518793471, createdTime=Sun May 10 08:41:28 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858926, encodeId=3c6a85892603, content=1月10号投稿<br> 2月15号回复审稿意见<br> 3月6号接收<br> 3月26号出版<br> 速度比较快,效率比较高,wiley旗下的要求比较严格,最后呈现的文章效果也比较漂亮,对于第一次发文章是一个不错的锻炼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Tue Mar 31 09:31:37 CST 2020, time=2020-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858296, encodeId=0d59858296f8, content=审稿速度:2.0<br>经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dee5413979, createdName=ms4391593229390302, createdTime=Wed Mar 11 23:25:18 CST 2020, time=2020-03-11, status=1, ipAttribution=)]
    2020-03-11 ms4391593229390302

    审稿速度:2.0
    经验分享:前几天刚刚审稿了一篇此期刊的文章,个人感觉,毕竟是4区的期刊,还是相对好投。在德化里的期刊,还是有一定的份量。希望会更好吧。

    0

共49条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map